Haus Bioceuticals   Report issue

For profit Phase 2
Founded: Oklahoma City OK United States (2009)
Status: No NME R&D (2009)

Organization Overview

First Clinical Trial
2016
NCT03848806
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2016

Timeline

NOW
  • Now

Alternative names

Haus Bioceuticals